In mouse models, its tumor-suppressor function is achieved by activating the cell cycle inhibitor gene, Cyclin Dependent Kinase Inhibitor 2A (Cdkn2a), which encodes the two proteins p16Ink4a and p19Arf (Bagchi and Mills, 2008). This evidence concerns the gene CDKN2A and neoplasm.